Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

It is squarely unethical to treat healthy pregnant women differently than other groups that are similarly at elevated risk of ...

The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...

Researchers have developed a new mRNA vaccine that overcomes the challenges associated with current mRNA therapeutic ...

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.